| 000 | 00000nam u22002058 4500 | |
| 001 | 000046135402 | |
| 005 | 20221201143300 | |
| 008 | 221130s2000 enk 0 eng d | |
| 015 | ▼a GBA0-Z0339 | |
| 020 | ▼a 1855734583 | |
| 035 | ▼a (KERIS)BIB000007897079 | |
| 040 | ▼a 211042 ▼c 211042 ▼d 211009 | |
| 082 | 0 4 | ▼a 338.476151 ▼2 23 |
| 084 | ▼a 338.476151 ▼2 DDCK | |
| 090 | ▼a 338.476151 ▼b B573 v | |
| 100 | 1 | ▼a Beynon, Karen. |
| 245 | 1 0 | ▼a Valuing pharmaceutical companies / ▼c Karen Beynon, Andrew Porter. |
| 260 | ▼a Cambridge : ▼b Woodhead, ▼c 2000. | |
| 300 | ▼a 256 p. ; ▼c 24 cm. | |
| 500 | ▼a Previous ed.: published as Pharmaceutical equities by Andrew Porter. | |
| 700 | 1 0 | ▼a Porter, Andrew D. |
Holdings Information
| No. | Location | Call Number | Accession No. | Availability | Due Date | Make a Reservation | Service |
|---|---|---|---|---|---|---|---|
| No. 1 | Location Sejong Academic Information Center/Social Science/ | Call Number 338.476151 B573 v | Accession No. 151362427 | Availability Available | Due Date | Make a Reservation | Service |
Contents information
Table of Contents
Part 1 The global pharmaceutical industry: Pharmaceuticals and the treatment of disease; Structure and internationalisation of the industry; Regional and national developments; Major changes in the pharmaceutical industry. Part 2 Analysis and evaluation of pharmaceutical companies: Valuing major quoted pharmaceutical companies; Valuing biotechnology companies and new venture financing; The assessment of research and development; The assessment of product sales potential. Part 3 Pharmaceutical equity trading: Key issues influencing pharmaceutical share price movement; Investment and trading strategy; Dealing in major equity markets.
Information Provided By: :
